SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037664
Filing Date
2022-11-14
Accepted
2022-11-14 17:01:07
Documents
47
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20220930.htm   iXBRL 10-Q 2349565
2 EX-31.1 tcon-ex311_7.htm EX-31.1 9366
3 EX-31.2 tcon-ex312_9.htm EX-31.2 9314
4 EX-32.1 tcon-ex321_8.htm EX-32.1 5966
5 EX-32.2 tcon-ex322_6.htm EX-32.2 5712
  Complete submission text file 0001564590-22-037664.txt   7165513

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcon-20220930.xsd EX-101.SCH 43424
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20220930_cal.xml EX-101.CAL 36019
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20220930_def.xml EX-101.DEF 122178
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20220930_lab.xml EX-101.LAB 301450
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20220930_pre.xml EX-101.PRE 217836
41 EXTRACTED XBRL INSTANCE DOCUMENT tcon-10q_20220930_htm.xml XML 1335339
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 221387241
SIC: 2836 Biological Products, (No Diagnostic Substances)